Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Net revenue	$ 1,033,744,000	$ 894,874,000	$ 1,984,038,000	$ 1,798,890,000
Cost of sales (exclusive of amortization shown separately below)	446,724,000	379,325,000	849,834,000	765,993,000
Amortization of acquired intangible assets	7,305,000	11,231,000	13,680,000	22,289,000
Total cost of sales	454,029,000	390,556,000	863,514,000	788,282,000
Gross profit	579,715,000	504,318,000	1,120,524,000	1,010,608,000
Operating Expenses
Selling, general, and administrative	211,672,000	185,362,000	404,860,000	362,082,000
Research and development	69,874,000	62,507,000	133,062,000	122,457,000
Amortization of acquired intangible assets	9,563,000	7,738,000	17,513,000	15,445,000
Acquisition related expenses	8,412,000	0	9,157,000	0
Total operating expenses	299,521,000	255,607,000	564,592,000	499,984,000
Income from operations	280,194,000	248,711,000	555,932,000	510,624,000
Other income (loss), net:
Interest (expense) income, net	(10,338,000)	(5,948,000)	(17,472,000)	(11,308,000)
Loss attributable to equity method investments (note 5)	(2,826,000)	(1,914,000)	(4,853,000)	(3,300,000)
Gain (loss) on equity investments (note 5)	8,368,000	(4,404,000)	5,088,000	1,208,000
Other, net	(1,707,000)	841,000	(3,211,000)	(1,150,000)
Total other income (loss), net	(6,503,000)	(11,425,000)	(20,448,000)	(14,550,000)
Income before income taxes	273,691,000	237,286,000	535,484,000	496,074,000
Income taxes	48,777,000	35,535,000	100,092,000	90,710,000
Net income	$ 224,914,000	$ 201,751,000	$ 435,392,000	$ 405,364,000
Basic earnings per share (dollars per share)	$ 1.53	$ 1.38	$ 2.97	$ 2.78
Diluted earnings per share (dollars per share)	1.53	1.37	2.95	2.76
Dividend declared per share (dollars per share)	$ 0.44	$ 0.42	$ 1.68	$ 0.84
Basic shares outstanding (000's) (shares)	146,704	145,990	146,568	145,835
Diluted shares outstanding (000's) (shares)	147,405	147,040	147,367	147,044
Total Sleep and Respiratory Care
Net revenue	$ 916,981,000	$ 795,840,000	$ 1,761,424,000	$ 1,602,339,000
Cost of sales (exclusive of amortization shown separately below)	406,303,000	343,194,000	770,146,000	692,876,000
Amortization of acquired intangible assets	1,343,000	1,072,000	2,572,000	1,972,000
Software as a Service
Net revenue	116,763,000	99,034,000	222,614,000	196,551,000
Cost of sales (exclusive of amortization shown separately below)	40,421,000	36,131,000	79,688,000	73,117,000
Amortization of acquired intangible assets	$ 5,962,000	$ 10,159,000	$ 11,108,000	$ 20,317,000